Chugai Pharmaceutical Co., Ltd. and Cheplapharm K.K. announced that Chugai will transfer the business in Japan concerning the anti-cancer agent Tarceva tablets 25, 100, and 150 to Cheplapharm. Chugai ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Roche's Tarceva and AstraZeneca's own Iressa are the current standard of care in first line treatments of patients with locally advanced or metastatic EGFR+ lung cancer, but Tagrisso looks set to ...

and Roche’s Tarceva (erlotinib). Over time. most targeted cancer drugs have their efficacy limited by the development of resistance mutations. As exon 20 mutated NSCLC is pretty rare the patient ...

With that said, not everyone on chemotherapy can take these drugs. Oral chemo drugs like Sprycel (dasatinib) or Tarceva (erlotinib) need stomach acid to be fully absorbed. By suppressing or ...

In patients with these mutations, targeted therapies like erlotinib (Tarceva) and gefitinib (Iressa) have improved survival rates by focusing on the specific genetic cause of the cancer. “In lung ...

[In the osimertinib arm], EGFR TKI monotherapy, at 27%, was probably mostly gefitinib [Iressa] or erlotinib [Tarceva] or continuing the third-generation EGFR-TKI post progression. That is what's ...

With that said, not everyone on chemotherapy can take these drugs. Oral chemo drugs like Sprycel (dasatinib) or Tarceva (erlotinib) need stomach acid to be fully absorbed. By suppressing or ...

Camber is reflecting on its 2024 milestones, noting that it launched 36 new generic products, filed 35 new ANDAs and received 53 ANDA approvals. “These milestones have allowed Camber to provide ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...